Christopher G Winearls
Overview
Explore the profile of Christopher G Winearls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sethi S, Beck Jr L, Glassock R, Haas M, De Vriese A, Caza T, et al.
Mayo Clin Proc
. 2023 Oct;
98(11):1671-1684.
PMID: 37804268
Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The...
2.
Sethi S, Beck Jr L, Glassock R, Haas M, De Vriese A, Caza T, et al.
Kidney Int
. 2023 Oct;
104(6):1092-1102.
PMID: 37795587
Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The...
3.
Thomson P, Mark P, Robertson M, White C, Anker S, Bhandari S, et al.
Kidney Int Rep
. 2022 Aug;
7(8):1793-1801.
PMID: 35967105
Introduction: Treatment of anemia in dialysis patients has been associated with increased risk of vascular access thrombosis (VAT). Proactive IV irOn Therapy in hemodiALysis Patients (PIVOTAL) was a clinical trial...
4.
Mark P, Jhund P, Walters M, Petrie M, Power A, White C, et al.
Kidney360
. 2022 Apr;
2(11):1761-1769.
PMID: 35372992
Background: People with kidney failure treated with hemodialysis (HD) are at increased risk of stroke compared with similarly aged people with normal kidney function. One concern is that treatment of...
5.
Macdougall I, Bhandari S, White C, Anker S, Farrington K, Kalra P, et al.
J Am Soc Nephrol
. 2020 Apr;
31(5):1118-1127.
PMID: 32253271
Background: Experimental and observational studies have raised concerns that giving intravenous (IV) iron to patients, such as individuals receiving maintenance hemodialysis, might increase the risk of infections. The Proactive IV...
6.
Hutchison C, Cockwell P, Moroz V, Bradwell A, Fifer L, Gillmore J, et al.
Lancet Haematol
. 2019 Mar;
6(4):e217-e228.
PMID: 30872075
Background: In multiple myeloma, severe acute kidney injury due to myeloma cast nephropathy is caused by pathogenic free light chain immunoglobulin in serum. High cutoff haemodialysis (HCO-HD) can remove large...
7.
Macdougall I, White C, Anker S, Bhandari S, Farrington K, Kalra P, et al.
N Engl J Med
. 2018 Oct;
380(5):447-458.
PMID: 30365356
Background: Intravenous iron is a standard treatment for patients undergoing hemodialysis, but comparative data regarding clinically effective regimens are limited. Methods: In a multicenter, open-label trial with blinded end-point evaluation,...
8.
Macdougall I, White C, Anker S, Bhandari S, Farrington K, Kalra P, et al.
Am J Nephrol
. 2018 Oct;
48(4):260-268.
PMID: 30304714
Background: Intravenous (IV) iron supplementation is a standard maintenance treatment for hemodialysis (HD) patients, but the optimum dosing regimen is unknown. Methods: PIVOTAL (Proactive IV irOn Therapy in hemodiALysis patients)...
9.
Storey B, Staplin N, Harper C, Haynes R, Winearls C, Goldacre R, et al.
Kidney Int
. 2018 Feb;
93(5):1165-1174.
PMID: 29395337
We aimed to compare long-term mortality trends in end-stage renal disease versus general population controls after accounting for differences in age, sex and comorbidity. Cohorts of 45,000 patients starting maintenance...
10.
Judge P, Harper C, Storey B, Haynes R, Wilcock M, Staplin N, et al.
J Am Soc Nephrol
. 2017 May;
28(9):2738-2748.
PMID: 28465378
Polycystic liver disease is a well described manifestation of autosomal dominant polycystic kidney disease (ADPKD). Biliary tract complications are less well recognized. We report a 50-year single-center experience of 1007...